nifedipine has been researched along with mocetinostat in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hörl, WH; Riegel, W; Schlosser, V; Spillner, G | 1 |
| Hörl, WH; Lang, K; Riegel, W; Schlosser, V; Spillner, G | 1 |
| De Vries, GW; Garst, M; Harcourt, D; Lee, G; McLaughlin, A; Perez, J; Wenzel, MB; Wheeler, LA | 1 |
| Brooke, MH; Majumdar, R; Nguyen, JT | 1 |
| Guarner, F; Malagelada, JR; Mourelle, M; Salas, A; Vilaseca, J | 1 |
| Jodal, M; Lundgren, O; Sörensson, J | 1 |
| Asakura, M; Asanuma, H; Funaya, H; Hori, M; Kitakaze, M; Kuzuya, T; Minamino, T; Mori, H; Node, K; Sakata, Y; Sanada, S; Shinozaki, Y; Tada, M; Takashima, S | 1 |
| Alp Yildirim, FI; Balci Ekmekçi, Ö; Demirci Tansel, C; Eker Kizilay, D; Ergin, B; Kucur, M; Topal, G; Uydeş Doğan, BS | 1 |
8 other study(ies) available for nifedipine and mocetinostat
| Article | Year |
|---|---|
Plasma levels of main granulocyte components during cardiopulmonary bypass.
Topics: Aged; Cardiopulmonary Bypass; Complement C3; Complement C3a; Complement C5; Dipyridamole; Enzyme-Linked Immunosorbent Assay; Female; Granulocytes; Humans; Lactoferrin; Lactoglobulins; Male; Middle Aged; Nifedipine; Pancreatic Elastase; Peroxidase | 1988 |
Release of granulocyte proteins during cardiopulmonary bypass: effect of different pharmacological interventions.
Topics: Adult; Cardiopulmonary Bypass; Dipyridamole; Female; Granulocytes; Humans; Lactoferrin; Male; Middle Aged; Nifedipine; Pancreatic Elastase; Peroxidase | 1988 |
The antiinflammatory activity of topically applied novel calcium-channel antagonists.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Calcium; Calcium Channel Blockers; Chemotaxis, Leukocyte; Clobetasol; Ear, External; Epidermis; Female; Humans; Hyperplasia; Inflammation; Mice; Neutrophils; Nifedipine; Peroxidase; Phosphatidylinositol Diacylglycerol-Lyase; Phosphodiesterase Inhibitors; Phospholipases A; Phosphoric Diester Hydrolases; Pituitary Neoplasms; Potassium Chloride; Pyrazoles; Terpenes; Tetradecanoylphorbol Acetate; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1995 |
Effects of calcium channel antagonists on the release of prostaglandin E2 from metabolically stressed muscle.
Topics: 2,4-Dinitrophenol; Animals; Calcium Channel Blockers; Dinitrophenols; Dinoprostone; Male; Muscles; Nifedipine; Peroxidase; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Verapamil | 1994 |
Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase.
Topics: Animals; Arginine; Colitis; Colon; Dexamethasone; Dilatation; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Guanidines; Hypoxanthines; Inflammation; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide Synthase; Peroxidase; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid | 1996 |
Involvement of nerves and calcium channels in the intestinal response to Clostridium difficile toxin A: an experimental study in rats in vivo.
Topics: Animals; Bacterial Toxins; Calcium Channel Blockers; Calcium Channels; Clostridioides difficile; Coloring Agents; Erythrocyte Volume; Evans Blue; Granisetron; Hexamethonium; Intestine, Small; Male; Nicotinic Antagonists; Nifedipine; Peroxidase; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Statistics, Nonparametric | 2001 |
Nifedipine limits infarct size via NO-dependent mechanisms in dogs.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dogs; Endothelium; Enzyme Inhibitors; Heart Rate; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Peroxidase | 2001 |
Barnidipine ameliorates the vascular and renal injury in L-NAME-induced hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Inflammation Mediators; Kidney; Kidney Diseases; Male; Malondialdehyde; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxidase; Rats, Wistar; Renal Artery; Time Factors; Vascular Remodeling; Vasoconstriction; Vasodilation | 2015 |